Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Ductal Adenocarcinoma, PDAC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07241676
What this trial is testing

Early Recurrence After Surgery for Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Recurrent Pancreatic Adenocarcinoma
Azienda Ospedaliera di Padova 500
Very early researchLooking for participantsNCT06122896
What this trial is testing

Prospective Screening for Pancreatic Ductal Adenocarcinoma in High-Risk Individuals

Who this might be right for
Pancreatic CancerPancreatic Ductal AdenocarcinomaPDAC+2 more
Dana-Farber Cancer Institute 5,000
Early research (Phase 1)Ended earlyNCT06599502
What this trial is testing

A Phase I/IIa Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AZD0022 as Monotherapy and in Combination With Anti-cancer Agents in Adult Participants With Tumours Harbouring a KRASG12D Mutation

Who this might be right for
Advanced Solid TumoursNon-Small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
AstraZeneca 17
Early research (Phase 1)Ended earlyNCT05605522
What this trial is testing

[225Ac]-FPI-2059 in Adult Participants With Solid Tumours

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Squamous Cell Carcinoma of Head and NeckColorectal Cancer+4 more
3B Pharmaceuticals GmbH 19
Not applicableLooking for participantsNCT04575363
What this trial is testing

RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
CHU de Reims 90
Testing effectiveness (Phase 2)WithdrawnNCT06592664
What this trial is testing

Certepetide Phase 1b/2a Continuous Infusion Trial in mPDAC

Who this might be right for
Pancreas CancerPancreatic CarcinomaPancreas Adenocarcinoma+5 more
Lisata Therapeutics, Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05379985
What this trial is testing

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)+1 more
Revolution Medicines, Inc. 754
Testing effectiveness (Phase 2)Looking for participantsNCT07702292
What this trial is testing

[68Ga]BED003 PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Who this might be right for
Colorectal CancerEpithelial Ovarian CancerGastric Cancer (GC)+2 more
Blue Earth Diagnostics 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07824960
What this trial is testing

Neoadjuvant Avutometinib/Defactinib and mFOLFIRINOX Combination Therapy in Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPDAC - Pancreatic Ductal AdenocarcinomaMetastatic Pancreatic Carcinoma+1 more
University of Virginia 31
Not applicableNot Yet RecruitingNCT07723781
What this trial is testing

Structured Case-Finding for Pancreatic Ductal Adenocarcinoma in Swiss Primary Care: A Feasibility Study

Who this might be right for
Pancreatic Adenocarcinoma (Ductal Adenocarcinoma)Early Detection of Cancer
Saskia Hendrich 50
Not applicableStudy completedNCT06720454
What this trial is testing

Study on Single-cell Regulons Atlas of Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Molecular Prognostic ModelRegulons
Tiejun Ying 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT07026279
What this trial is testing

Narmafotinib Given in Combination With Modified FOLFIRINOX in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Amplia Therapeutics Limited 67
Early research (Phase 1)UnknownNCT04612530
What this trial is testing

PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerMetastatic Pancreatic Cancer
Amsterdam UMC, location VUmc 18
Not applicableStudy completedNCT04726956
What this trial is testing

A Combination of AKR1B10 and CA19-9 Improves the Diagnosis of PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 258
Early research (Phase 1)Looking for participantsNCT07261631
What this trial is testing

Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-Small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast Cancer+3 more
Novartis Pharmaceuticals 180
Early research (Phase 1)Looking for participantsNCT07030283
What this trial is testing

Intraperitoneal Paclitaxel With NALIRIFOX for Pancreatic Ductal Adenocarcinoma With Peritoneal Carcinomatosis

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
University of Colorado, Denver 10
Not applicableLooking for participantsNCT07723261
What this trial is testing

Hellenic Evaluation of the Long-Term Safety and Efficacy of NalIriFOx as a 1st-line Therapy in Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Hellenic Cooperative Oncology Group 70
Testing effectiveness (Phase 2)Looking for participantsNCT06261359
What this trial is testing

CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Qilu Pharmaceutical Co., Ltd. 120
Not applicableLooking for participantsNCT07155850
What this trial is testing

Early Feasibility Clinical Investigation to Assess YntraDose™ as a Neoadjuvant Treatment for LA-PDAC

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Locally AdvancedUnresectable
BetaGlue Therapeutics SpA 10
Not applicableLooking for participantsNCT07226154
What this trial is testing

Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
City of Hope Medical Center 200
Next Page